medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2018, Number 6

<< Back Next >>

Rev Mex Urol 2018; 78 (6)

Lesions due to human papillomavirus in urology patients

Guerrero-Putz MD, Maya-Epelstein A, García-Galaviz R, Olvera-Posada D

Language: Spanish
References: 35
Page: 463-473
PDF size: 408.73 Kb.


ABSTRACT

Human papillomavirus is one of the most common sexually transmitted diseases worldwide and is the causal agent of anogenital warts. It is a highly contagious disease that has a predilection for skin keratinocytes and its entry pathway tends to be areas exposed through microtrauma or abrasions. Males who have sex with males and immunocompromised patients are the groups that have the greatest predisposition to infection by human papillomavirus. The diagnosis of lesions is clinical for the most part and there is currently no consensus on treatment for those lesions for the entire population. At present, there are different management options, whose indications depend on the experience of the physician, patient preference, and treatment availability, among others.


REFERENCES

  1. Centers for Diseases Control and Prevention. Human Papillomavirus (HPV) Statistics. Dirección URL: . (Consulta: noviembre 2017).

  2. Giuliano AR, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17(8):2036-43. DOI: 10.1158/1055-9965.EPI-08-0151

  3. Centers for Diseases Control and Prevention. Human Papillomavirus (HPV) Infection. 2015 Sexually Transmitted Diseases Treatment Guidelines. Dirección URL: . (Consulta: noviembre 2017).

  4. Carroll CJ, et al. European guideline for the management of anogenital warts. J. Eur. Acad. Dermatology Venereol 2013;27(3):e263-e270. DOI: 10.1111/j.1468- 3083.2012.04493.x

  5. Scheinfield N. Condylomata acuminata (anogenital warts): Management of external condylomata acuminata in men. UpToDate. Dirección URL: . (Consulta: mayo, 2018).

  6. Sistema de Salud. Guía de Práctica Clínica, Diagnóstico y tratamiento verrugas vulgares. Catálogo maestro de guías de práctica clínica. SSA-250-10.

  7. Modificación a la Norma Oficial Mexicana NOM-014- SSA2-1994, para la Prevención, Tratamiento y Control del Cancer del Cuello del Utero y Mamario en la Atención primaria, para quedar como NOM-014-SSA2-1994, para la Prevención, Detección, Diagnóstico, Tratam. Dirección URL: . (Consulta: junio, 2018).

  8. Karen C, et al. Human Cancer Viruses. In: Jawetz M, editor. Adelberg’s Medical Microbiology. 27th editon. New York: McGraw-Hill. 2016).

  9. Secretaria de Salud México. Subsistema de Notificación Semanal de Casos Nuevos de Enfermedades Información Epidemiológica de Morbilidad 2013. Dirección URL: .

  10. Dunne EF, et al. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011;53(Suppl 3):143-S152. DOI: 10.1093/cid/cir703

  11. Boda D, et al. Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol 2018;52(3):637-655. DOI: 10.3892/ijo.2018.4256

  12. Levinson W. DNA nonenveloped viruses. In: Review of medical microbiology and immunology. 14th edition. New York: McGraw-Hill, 2016.

  13. Goldsmith LA, et al. Human papilloma virus infections. In: Fitzpatrick’s Dermatology in General Medicine. 8th edition. New York: McGraw-Hill, 2012.

  14. Kasper DL, et al. Human papillomavirus infections. In: Harrison’s Principles of Internal Medicine. 19th edition. New York: McGraw-Hill, 2015.

  15. Sichero L, et al. High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study. BMC Infect Dis 2014;14:677. DOI: 10.1186/s12879-014-0677-y

  16. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32(Suppl 1):7-15. DOI: 10.1016/j.jcv.2004.12.006

  17. Pierce Campbell CM, et al. Cutaneous human papillomavirus types detected on the surface of male external genital lesions: A case series within the HPV Infection in Men Study. J Clin Virol 2013;58(4):652-9. DOI:10.1016/j. jcv.2013.10.011

  18. Thurgar E, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technol Assess 2016;20(24):1-486. DOI: 10.3310/hta20240

  19. Krieger JN. Sexually transmitted diseases. In: Smith A. Tanagho’s general urology. 18th edition. New York: McGraw- Hill, 2015.

  20. Lacey CJ, et al. 2011 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 2013;27(3):e263-70. DOI: 10.1111/j.1468- 3083.2012.04493.x

  21. Krawczyk E. et al. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 2008;173(3):682-8. DOI: 10.2353/ ajpath.2008.080280

  22. Jenkins D, et al. Histological and immunocytochemical study of cervical intraepithelial neoplasia (CIN) with associated HPV 6 and HPV 16 infections. J Clin Pathol 1986;39(11):1177-80.

  23. Stamm AW, et al. Urologic dermatology: A review. Curr Urol Rep 2017;18(8):62. DOI: 10.1007/s11934-017-0712-9

  24. Centers for Diseases Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines. Anogenital warts. Dirección URL: . (Consulta: marzo, 2018).

  25. Schöfer H, et al. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults. Int J STD AIDS 2017;28(14):1433-1443. DOI: 10.1177/0956462417711622

  26. Rosenblatt A, et al. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases. Int J STD AIDS 2012;23(12):909-10. DOI: 10.1258/ijsa.2012.012076

  27. Fichman Y, et al. Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study. Lasers Med Sci 2018;33(4):773-777. DOI: 10.1007/s10103-017-2413-5

  28. Juhl ME, et al. Combined treatment of anogenital HPV infection with cryodestruction, podophyllin 25% and post-ablation immunomodulation with sinecatechins 15% ointment - a retrospective analysis. Int J STD AIDS 2016;27(12):1071-1078. DOI: 10.1177/0956462415607375

  29. Peyrí Rey E. El urólogo ante la infección del virus del papiloma humano. Actas Urol Esp 2010;34(1):10-11. DOI: 10.1016/S0210-4806(10)70004-8

  30. American Academy of Family Physicians. American Family Physician 70, (American Academy of Family Physicians, 1970). Dirección URL: .

  31. Asociación Mexicana de Vacunología. Virus de Papiloma Humano. Vacuna. Dirección URL: . (Consulta: mayo, 2018).

  32. Merriel SWD, et al. Knowledge and Attitudes of General Practitioners and Sexual Health Care Professionals Regarding Human Papillomavirus Vaccination for Young Men Who Have Sex with Men. Int J Environ Res Public Health 2018;15(1):piiE151. DOI: 10.3390/ijerph15010151

  33. Richter S, et al. Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Can Urol Assoc J 2013;7(11-12):E797-811. DOI: 10.5489/cuaj.1794

  34. Camargo CC, et al. Quality of life in men diagnosed with anogenital warts. An Bras Dermatol 2017;92(3):427-429. DOI: 10.1590/abd1806-4841.20175282

  35. Bertram CC, Magnussen L. Informational needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 2008;20(9):455-462. DOI: 10.1111/j.1745-7599.2008.00341.x




2020     |     www.medigraphic.com